These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28501941)

  • 1. Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.
    Zhang L; Wang L; Shahzad KA; Xu T; Wan X; Pei W; Shen C
    Cancer Immunol Immunother; 2017 Sep; 66(9):1229-1241. PubMed ID: 28501941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Artificial Antigen-Presenting Cell Delivering 11 Immune Molecules Expands Tumor Antigen-Specific CTLs in
    Zhang L; Song S; Jin X; Wan X; Shahzad KA; Pei W; Zhao C; Shen C
    Cancer Immunol Res; 2019 Jul; 7(7):1188-1201. PubMed ID: 31113806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
    Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
    Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
    Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth.
    Shen C; Cheng K; Miao S; Wang W; He Y; Meng F; Zhang J
    Immunol Lett; 2013 Feb; 150(1-2):1-11. PubMed ID: 23328744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response.
    Lu X; Jiang X; Liu R; Zhao H; Liang Z
    Cancer Lett; 2008 Nov; 271(1):129-39. PubMed ID: 18621475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale artificial antigen presenting cells for T cell immunotherapy.
    Perica K; De León Medero A; Durai M; Chiu YL; Bieler JG; Sibener L; Niemöller M; Assenmacher M; Richter A; Edidin M; Oelke M; Schneck J
    Nanomedicine; 2014 Jan; 10(1):119-29. PubMed ID: 23891987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction.
    Rhodes KR; Meyer RA; Wang J; Tzeng SY; Green JJ
    Acta Biomater; 2020 Aug; 112():136-148. PubMed ID: 32522714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.
    Steenblock ER; Fadel T; Labowsky M; Pober JS; Fahmy TM
    J Biol Chem; 2011 Oct; 286(40):34883-92. PubMed ID: 21849500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
    PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
    Sun X; Han X; Xu L; Gao M; Xu J; Yang R; Liu Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
    Sunshine JC; Perica K; Schneck JP; Green JJ
    Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
    Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
    Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
    Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
    Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Antigen-Presenting Cells for Immunotherapies.
    Siefert AL; Fahmy TM; Kim D
    Methods Mol Biol; 2017; 1530():343-353. PubMed ID: 28150213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.
    Ye Q; Loisiou M; Levine BL; Suhoski MM; Riley JL; June CH; Coukos G; Powell DJ
    J Transl Med; 2011 Aug; 9():131. PubMed ID: 21827675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.